- ISIN
- US1429221294
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- IPO Date
- Sep 23, 2021
Highlights
- Market Cap
- $579.59K
- Enterprise Value
- $879.26K
- EPS (TTM)
- -$1.04
- Total Revenue (TTM)
- $1.79M
- Gross Profit (TTM)
- $1.02M
- EBITDA (TTM)
- -$6.70M
- Year Range
- $0.23 - $8.27
- ROA (TTM)
- -415.93%
- ROE (TTM)
- 99.07%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
XAGE Performance Chart
Longevity Health Holdings, Inc (XAGE) is up 1.4% since the beginning of the year. At $0 per share, XAGE is trading 96.3% below its 52-week high of $8.
Loading charts...
Returns By Period
Longevity Health Holdings, Inc (XAGE) has returned 1.38% so far this year and -88.66% over the past 12 months.
Longevity Health Holdings, Inc
- 1D
- 4.29%
- 1M
- 1.69%
- YTD
- 1.38%
- 6M
- -33.82%
- 1Y
- -88.66%
- 3Y*
- -90.06%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
XAGE Monthly Returns History
Based on dividend-adjusted daily data since Sep 23, 2021, XAGE's average daily return is -0.17%, while the average monthly return is -7.66%.
Historically, 43% of months were positive and 57% were negative. The best month was Jan 2025 with a return of +55.5%, while the worst month was Sep 2025 at -72.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, XAGE closed higher 35% of trading days. The best single day was Jan 2, 2025 with a return of +148.0%, while the worst single day was Jul 24, 2023 at -36.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.59% | -3.48% | 4.60% | 6.19% | -3.54% | 1.69% | 1.38% | ||||||
| 2025 | 55.50% | -45.85% | -46.77% | 24.70% | -29.49% | -23.64% | 15.87% | -13.02% | -72.04% | -16.90% | -8.64% | -44.17% | -96.41% |
| 2024 | -10.76% | -5.59% | -20.25% | -21.87% | 24.50% | -46.59% | -20.30% | -39.81% | -37.07% | -17.26% | -9.09% | -7.58% | -92.67% |
| 2023 | 1.34% | 0.20% | 0.79% | 0.20% | 0.59% | 0.68% | -66.21% | 4.02% | -0.48% | -42.27% | 20.67% | 51.79% | -61.58% |
| 2022 | 0.83% | -0.62% | 1.04% | -0.41% | -0.52% | 0.31% | 0.52% | 0.10% | -0.00% | 0.62% | 0.92% | 0.28% | 3.09% |
| 2021 | -3.59% | -0.21% | 0.52% | -0.93% | -4.18% |
Benchmark Metrics
Longevity Health Holdings, Inc has an annualized alpha of -35.70%, beta of 0.20, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 23, 2021.
- This stock participated in 206.21% of S&P 500 Index downside but only -127.12% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.20 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -35.70%
- Beta
- 0.20
- R²
- 0.00
- Upside Capture
- -127.12%
- Downside Capture
- 206.21%
Return for Risk
Risk / Return Rank
XAGE ranks 20 for risk / return — below 20% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Longevity Health Holdings, Inc (XAGE) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XAGE | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.21 | ||
| Sortino ratioReturn per unit of downside risk | -2.69 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.32 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 2.46 | -3.38 |
| Martin ratioReturn relative to average drawdown | -1.05 | 10.92 | -11.97 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Longevity Health Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Longevity Health Holdings, Inc was 99.92%, occurring on Mar 9, 2026. The portfolio has not yet recovered.
The current Longevity Health Holdings, Inc drawdown is 99.91%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.92%Mar 2026 | 2y 8mo | — | 2y 11moJul 2023 - now |
Bear market2022 | -4.38%Feb 2022 | 4mo 26d | 11mo 13d | 1y 4moSep 2021 - Jan 2023 |
2023 pullback2023 | -3.48%Jul 2023 | 10d | 4d | 14dJun 2023 - Jul 2023 |
2023 pullback2023 | -0.49%Mar 2023 | 0s | 8d | 8dMar 2023 - Mar 2023 |
2023 pullback2023 | -0.49%Mar 2023 | 0s | 1mo 12d | 1mo 12dMar 2023 - May 2023 |
Drawdown Indicators
| XAGE | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.92% | -56.78% | -43.14% |
Max Drawdown (1Y)Largest decline over 1 year | -95.62% | -9.10% | -86.52% |
Max Drawdown (3Y)Largest decline over 3 years | -99.92% | -18.90% | -81.02% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.91% | -3.21% | -96.70% |
Average DrawdownAverage peak-to-trough decline | -56.30% | -10.71% | -45.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 84.02% | 2.04% | +81.98% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Longevity Health Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Longevity Health Holdings, Inc is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for XAGE relative to other companies in the Household & Personal Products industry. Currently, XAGE has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with XAGE
Add Longevity Health Holdings, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with XAGE